Mutants of type 5 adenovirus that fail to express the EIB-gene-encoded 175-amino-acid 
The El region of type 5 adenovirus contains two overlapping transcription units which encode proteins that are essential for a productive viral infection of permissive human cells and for transformation of nonpermissive rodent cells (for a review, see reference 22) . Transcription initiation from the ElA cap site results in the production of two differentially spliced mRNAs that encode proteins of 289 and 243 amino acids (289R and 243R) (10, 15, 34, 46) . By using a variety of genetic approaches it has been demonstrated that the 289R protein is necessary for modulating the rate of transcription from several viral early promoters (9, 13, 31, 45, 50) and some cellular genes (21, 54) , probably through its modification of some preexisting or induced cellular transcription factors (35, 67) . It has been suggested that both ElA proteins share domains which may suppress the expression of viral and cellular enhancer-dependent promoters (11, 28, 52, 59) and that both proteins are necessary for the induction of cellular DNA synthesis and cell proliferation (33, 38, 49, 53) . Both proteins are required to establish and maintain the transformed cell phenotype by using primary or continuous cultures of rodent cells (25, 30, 32, 40, 43, 51, 69) . When these proteins are expressed independently in rodent cells, foci do develop, but they can be phenotypically distinguished from the foci established by both ElA proteins; this implies that both proteins contribute to the characteristics of the transformed cell (5, 6, 25, 40) .
Transcription from the E1B gene results in the expression of at least five differentially spliced mRNA species (10, 15, 17, 34, 60) . During a productive viral infection of human HeLa cells, the relative abundance of the two predominant mRNAs, 22S and 13S, appears to be controlled at the posttranscriptional level (42) . These mRNAs encode proteins of 495R and 175R, with the 22S mRNA having the capability of encoding both proteins (1, 12) . The additional mRNAs represent a minor component and encode proteins that are related to the 495R protein (1, 37) .
The 495R protein has been shown to play a role in the shutoff of host cell protein synthesis and the efficient nuclear-cytoplasmic transport of late viral mRNAs in the infected cell (3, 4, 47) . In cooperation with ElA proteins and the ElB-encoded 175R protein, this protein appears to play a role both in initiating and in maintaining the transformed cell phenotype (2, 8, 47) . When introduced into nonpermissive rodent cells, viruses that express truncated forms of this protein induce foci at a reduced frequency and with fewer transformed-cell characteristics as the truncation approaches the amino terminus of the protein (2) . However, the complete absence of 495R protein expression still results in focus formation, suggesting that this protein is involved in a secondary pathway leading to the transformed state.
The role of the 175R protein in the process of viral replication and cellular transformation is less clear. The absence of 175R protein expression in virus-infected HeLa cells has no effect on the kinetics of viral DNA replication (8, 47; L. Babiss, H. Young, and H. Ginsberg, unpublished observations) but does result in the cell-type-specific degradation of both viral and host DNAs (36, 47, 55-57, 65, 66) . It is thought that the localization of the acylated form of this CELLULAR TRANSFORMATION AND ADENOVIRUS GENE EXPRESSION 4635 protein (39) to the nuclear membrane serves as a physical deterrent to the entry of cytoplasm nuclease into the infected-cell nucleus (62) . In growth-arrested cells, the absence of 175R protein expression results in increased transcription initiation from the ElA gene, suggesting that this protein exerts a negative effect on viral early-gene expression (64) .
In contrast to studies using viruses containing defined mutations in E1B products, transient expression assays using plasmid vectors have led to a series of observations which suggest that the 175R protein may stimulate transcription from several cellular genes and the viral ElA gene, through their respective enhancer elements (44, 68) . These studies have also shown that this protein can relieve enhancer suppression that is mediated by the viral ElA gene products.
Viruses that fail to express the 175R protein or encode potentially truncated forms of this protein are unable to transform a number of different rodent cells, even at high multiplicities of infection (2, 8, 14, 47) . This has led us to propose the hypothesis that the ElB-encoded 175R protein may be functioning in this dominant manner as a result of its modulation of viral early-gene expression (most likely E1A) or its association with the ElA proteins in a pathway that elicits the cascade of cellular events leading to the generation of a transformed cell.
To differentiate between these two regulatory mechanisms, and to determine whether viruses expressing either the ElA 289R or 243R protein (40, 41) (49) .
The production of stable mRNAs from the viral early genes and cellular IGN gene promoters was scored by their ability to protect from nuclease digestion a labeled RNA probe prepared from an sp6 subclone of a portion of the viral or cellular gene. The same viral infections used to score transcription were used as a source of total cytoplasmic RNA. Electrophoresis and autoradiography were used to identify and size the RNA segments.
The sp6 protection assay for the E1B and E2A genes has been previously described and results in protected RNAs of 183 and 195 nucleotides for E1B and 260 nucleotides for E2A (20) . These regions are noted in Fig. 2B . The ElA probe was a BamHI (0.0 m.u.)-to-XbaI (3.8 m.u.) DNA fragment cloned into the plasmid pGEM1. Antisense RNA was generated by the sp6 RNA polymerase after linearization of the plasmid with EcoRI. This probe protects from RNase digestion RNAs of 613 (13S specific), 467 (12S specific), and 111 (12S and 13S specific) nucleotides (Fig. 2A) . The IGN 5' probe extends from nucleotides -154 to +57 of the mouse IGN heavy chain promoter and protects an RNA of 57 nucleotides (see Fig. SA ).
RESULTS

Construction of viral mutants. Various combinations of
ElA and E1B mutations were joined on a plasmid vector and introduced into a full-length viral genome (In340) by in vivo overlap recombination in human 293 cells. The viral mutants that were obtained by using this approach are diagrammed in Fig. 1 , with the position of the mutation aligned with the coding regions of the ElA and E1B genes. All the ElA mutations were paired with ElB mutations that affected either the 175R or 495R protein. The latter ElB mutation was used as a control, since previous studies had shown that its absence did not completely abolish focus formation upon virus infection of CREF cells (2) .
The viral mutant AdShrl contains a point mutation in the first exon of the 13S-specific protein coding region (50) . As a result, this virus encodes a wild-type 243R protein and a truncated form of the 289R protein. H2dl1500 contains a small deletion that removes the ElA 13S splice donor site and was engineered into an Ad2wt parental virus genome (40) . As a consequence, this virus expresses only the ElA 243R protein. pm975 virus expresses only the ElA 13S mRNA-specific 289R protein, and this mutation was engineered into a d1309 virus background (41) . The mutation in the H5dl112 virus that affects the expression of the ElB 175R protein results in a potentially truncated form of this protein that could not be detected in infected HeLa cells by using a polyclonal serum raised in rabbits against the wildtype protein (3) (data not shown). Similarly, H5dl163 virus encodes a truncated form of the 495R protein, although this protein could be observed in nuclei of virus-infected HeLa cells by using a polyclonal serum raised against the wild-type form of this protein (4).
Analysis of the transforming ability of viral mutants. CREF cells were infected with each of the viruses shown in Fig. 1 at a multiplicity of infection of 10 PFU per cell. After a 6-week incubation period at 37°C, the cells were fixed and stained and the foci per dish were quantitated. As Fig. 1 could be influencing the frequency of transformation. To distinguish between these two possibilities, the H2dl1500 and AdShrl ElA mutations were engineered into an 1n340 genome (1500-340 and hrl-340) by overlap recombination (overlap occurred between 3.8 and 15.5 m.u.) or ligation (at 60 m.u.). When these viruses were used to infect CREF cells, the frequency of focus formation was reduced by three-to fourfold relative to the frequencies obtained with H2dl1500 and AdShrl parental viruses. These observations suggested that either additional mutations were present on the AdShrl or H2dl1500 genomes that were contributing to the increased frequency of transformation observed or the viral E3 gene was involved in modulating the frequency of transformation. The lack of viral VAII RNA expression, observed for the viruses isolated by overlap recombination (due to the XbaI site mutation in the In340 virus), did not appear to be contributing to the transformation phenotype, since viruses that expressed the VAII RNAs and no E3 gene products retained this phenotype. The two approaches used to introduce the ElA 289R protein mutations into an E3-deficient genome suggested that if additional mutations existed, they had to extend from 60 to 100 m.u. Since AdShrl and H2dl1500 were isolated from AdS and Ad2, respectively, the likelihood that a mutation other than E3 is responsible for the transformation deficiency cannot at present be excluded but is unlikely. Therefore, E3 expression appears to affect the frequency of incomplete focus formation by the ElA 243R protein. This result was not previously observed when the ElA 289R protein was also present, since d1309 and Ad5wt viruses transform CREF cells at similar frequencies (2). E1B 175R protein does not dramatically influence viral early gene expression. In CREF cells infected with the viruses shown in Fig. 1 , the accumulation of viral early cytoplasmic mRNAs was analyzed by RNA protection assays using a series of early-gene-specific 32P-labeled antisense RNA probes. Cytoplasmic RNA was isolated at 10 h postinfection from CREF cells infected at 10 PFU per cell. Among viruses that expressed either ElA polypeptide, the steady-state levels of early mRNAs from regions E1B and E2A were the same for all the viruses regardless of which E1B gene product was expressed (Fig. 2) . The decrease in mRNA accumulation observed among viruses that do not express the ElA 289R protein confirms the role of this protein as a transcriptional activator. We repeatedly observed a twofold decrease in the accumulation of the viral ElA mRNAs, for all the viruses that did not express the E1B 175R protein. To confirm that a potentially truncated form of the 175R protein which could be expressed as a result of the mutation in the H5dl112 was not influencing these observations, the pm1722 virus was used (8) . This virus contains a mutation that prevents the translation of the 175R protein and upon infection of CREF cells results in a similar twofold decrease in ElA mRNA accumulation ( Fig. 2 ; additional data not shown). In all cases there did not appear to be any changes in the relative abundance of the ElA 13S and 12S mRNAs, making it unlikely that the 175R protein was exerting a posttranscriptional effect on viral ElA gene expression.
In HeLa cells infected with the same viruses for the same period of time, no differences in mRNA accumulation could be observed as a consequence of viral 175R protein expression (Fig. 3) To determine whether the 175R protein could be modulating viral early-gene expression at the level of transcriptional initiation, CREF and HeLa cells were infected with each virus shown in Fig. 4 (10 PFU per cell) . At 10 h postinfection, nuclei were isolated and incubated with labeled triphosphate ([32P]UTP) to allow previously initiated RNA polymerases to elongate. Nuclear RNA was isolated, hydrolyzed with sodium hydroxide, hybridized to excess DNA representing the viral early genes on nitrocellulose filters (the same amount of total labeled RNA was used for each hybridization reaction and represented similar numbers of nuclei), treated with ribonucleases, and exposed to autoradiography. The rates of transcription from the viral early genes did not appear to be influenced by the lack of 175R protein expression in both HeLa and CREF cells (Fig. 4) . This was confirmed by densitometric tracing of each signal and normalizing for the length of each probe to show that transcription in any one transcription unit was uniform. The
N~'' transcription rate for the cellular actin gene was used to control for input counts and was similar for all the hybridization reactions. These results suggest either that the 175R protein is exerting a transient effect on the stability of the ElA mRNAs early in the viral replicative cycle or perhaps simply that the transcription assay is not sensitive enough to detect a twofold difference.
It could be argued that the lack of an E1B protein effect by viruses that express only the ElA 243R protein is irrelevant, since wild-type E1B expression is so low. However, if HeLa and CREF cell infections are allowed to proceed for 30 h in the absence of viral DNA replication (by the addition of cytosine arabinoside at 40 ,ug/ml), E1B mRNA levels accumulate to the level observed for wild-type virus at 8 h postinfection. Under these conditions, there still appears to be no effect of the lack of 175R protein expression on early viral gene expression (data not shown).
E1B 175R protein does not affect the mouse IGN promoter activity. Yoshida et al. (68) have reported that the Ad2 175R protein can enhance the expression from the mouse IGN heavy chain promoter through its enhancer in CREF cells. While it is surprising that this tissue-specific promoter can function in CREF cells, we have confirmed that the IGN promoter is functioning after an Ig454 virus infection, and the activity of this promoter is dependent upon the IGN enhancer ( (31) , to supply ElA proteins in trans. Two assays were used to quantitate the transcriptional activity from the viral IGN promoter, sp6 RNA protection and nuclear run-on assays. By using a labeled antisense sp6 RNA probe specific for the 5' end of the IGN first exon, it is clear that E1B protein expression had no effect on the accumulation of IGN promoter-expressed mRNAs (Fig. 5A , compare lanes Ig454 and Ig454.1b). Furthermore, coinfecting with HSdl313 virus to supply ElA proteins in trans appeared to decrease IGN-viral mRNA accumulation, regardless of E1B gene expression. Since the stability of the IGN-viral hybrid mRNAs could vary as a result of differences at the 3' ends of these mRNAs, rates of transcription initiation were determined. The intensities of the Ig and E1B dots were similar for both viruses (Fig. SC) , suggesting that the E1B 175R protein was not exerting any effect on the rate of transcription initiation from the IGN promoter on the viral genome. The intensities of the E1B signals suggest that the rates of Ig and E1B transcription are similar. The differences in the intensities of the dots reflect the length of the DNA sequence that is transcribed. To confirm that E1B gene expression was occurring in IG454.lb virus-infected cells, an sp6 RNA protection assay which scored the 3' ends of the E1B mRNAs was performed (Fig. 5B) proteins are present the 175R protein does not appe capable of blocking the suppression caused through enhancer element. These results were confirmed by mouse myeloma cell line, J558, although the rate scription initiation from the IGN promoter on t] genome was 5-to 10-fold higher (data not shown).
ElA proteins in the pathways leading to the conversion of the normal cell to the transformed phenotype.
Using a series of viruses containing mutations affecting various combinations of ElA and E1B polypeptides, we have demonstrated that the lack of 175R protein expression * @ always leads to a transformation-defective phenotype, regardless of the ElA protein that is expressed (Table 1) . Additional studies using virus-infected HeLa and CREF *I *@ cells showed that this transformation defect was not the .0 * result of a decrease in the rate of transcription initiation from the viral early-gene promoters (Fig. 2-4 (7, 25, 40) . We have also observed that the lack of E1B 495R protein expression does not dramatically affect the efficiency of transformation when the E1B 175R and ElA 243R proteins are expressed. The decrease in focus formation that is observed is more likely attributable to the lack of viral E3 gene expression. This effect of altered E3 gene expression does not appear to change the frequency of focus formation when the ElA 289R protein is expressed and may suggest that this ElA gene product can either complement the E3 protein defect or initiate an alternate pathway leading to cellular transformation that no longer requires the E3 proteins. While E3 gene expression is not required for a productive viral replicative cycle in cultured cells, recent evidence implicates at least two glycoproteins that are encoded by this gene as important for the spread of adenovirus in humans (23) .
In contrast to the findings mentioned above, the absolute frequency of focus formation by viruses that express only the 175R and ElA 289R proteins is more markedly decreased by the absence of wild-type 495R protein expression (Table  1) . This again would suggest that the 495R protein may interact with or be involved in a similar pathway as the ElA 289R protein that leads to cellular transformation. Similar genetic and biochemical studies proposed earlier could be approached to investigate these protein interactions.
Many studies have suggested that the 175R protein can increase the rate of viral ElA gene expression, through the ElA enhancer element (44, 68) . However, we have shown that viruses which fail to express this protein display wildtype rates of transcription initiation from the ElA cap site. The differences between our findings and those previously reported are most likely attributable to scoring viral gene expression on a plasmid vector versus a viral genome. These differences may be explained as follows: (i) the expression of additional viral or cellular genes or both during a virus infection could diminish the role of the E1B 175R protein in its ability to modulate ElA gene expression; (ii) the presence of the 175R protein in transfected cells could lead to greater stability of the plasmids and therefore more accumulated mRNAs, with no impact on the rate of RNA polymerase initiation; (iii) the ability of the 175R protein to physically interact with the EIA enhancer could be affected by the location of these sequences on a viral genome or supercoiled plasmid. In fact, we have recently shown that the SV40 enhancer will not function in the region of the viral ElA gene enhancer on a viral genome, but when these same sequences are localized in the same region and situated on a plasmid they display enhancer function (L. Babiss, unpublished observation).
White and Stillman have suggested that E1B 175R protein may suppress the activity of the ElA promoter, since a virus that fails to express this protein overexpresses ElA mRNAs in growth-arrested WI38 cells (64) . These authors have recently shown that the accumulation of ElA and E2A polypeptides and the onset of viral DNA replication are accelerated in HeLa cells infected with 175R-protein-defective virus, relative to a wild-type virus infection (63) . However, this was not confirmed at the level of RNA synthesis and could suggest a posttranscriptional or posttranslational role for this E1B protein.
